JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M204130200 on May 24, 2002

J. Biol. Chem., Vol. 277, Issue 32, 28545-28553, August 9, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/32/28545    most recent
M204130200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yus-Nájera, E.
Right arrow Articles by Villarroel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yus-Nájera, E.
Right arrow Articles by Villarroel, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Identification and Characterization of a Noncontinuous Calmodulin-binding Site in Noninactivating Voltage-dependent KCNQ Potassium Channels*

Eva Yus-Nájera, Irene Santana-Castro, and Alvaro VillarroelDagger

From the Instituto Cajal, Consejo Superior de Investigaciones, Avenida, Dr. Arce 37, 28002 Madrid, Spain

Received for publication, April 29, 2002, and in revised form, May 22, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We show here that in a yeast two-hybrid assay calmodulin (CaM) interacts with the intracellular C-terminal region of several members of the KCNQ family of potassium channels. CaM co-immunoprecipitates with KCNQ2, KCNQ3, or KCNQ5 subunits better in the absence than in the presence of Ca2+. Moreover, in two-hybrid assays where it is possible to detect interactions with apo-CaM but not with Ca2+-bound calmodulin, we localized the CaM-binding site to a region that is predicted to contain two alpha -helices (A and B). These two helices encompass ~85 amino acids, and in KCNQ2 they are separated by a dispensable stretch of ~130 amino acids. Within this CaM-binding domain, we found an IQ-like CaM-binding motif in helix A and two overlapping consensus 1-5-10 CaM-binding motifs in helix B. Point mutations in helix A or B were capable of abolishing CaM binding in the two-hybrid assay. Moreover, glutathione S-transferase fusion proteins containing helices A and B were capable of binding to CaM, indicating that the interaction with KCNQ channels is direct. Full-length CaM (both N and C lobes) and a functional EF-1 hand were required for these interactions to occur. These observations suggest that apo-CaM is bound to neuronal KCNQ channels at low resting Ca2+ levels and that this interaction is disturbed when the [Ca2+] is raised. Thus, we propose that CaM acts as a mediator in the Ca2+-dependent modulation of KCNQ channels.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The KCNQ transmembrane proteins are members of a family of voltage-dependent potassium selective channels that are involved in the control of cellular excitability. Remarkably, mutations in four of the five known members of this family have been associated with different hereditary human disorders. While mutations in the KCNQ1 subunit (KvQT1) lead to arrhythmia in the human long QT syndrome, mutations in KCNQ2 or KCNQ3 are associated with a benign form of epilepsy. It has also been shown that KCNQ4 is mutated in a dominant form of progressive hearing loss (1).

With regards to the normal physiology of this protein family, the KCNQ2 and KCNQ3 subunits have been shown to form M-type potassium channels whose expression is restricted to neuronal tissue (2). Moreover, in some brain areas and neuronal tissues, KCNQ4 and KCNQ5 also contribute to the formation of M channels, suggesting that the different combinations of KCNQ subunits may be in part responsible for the diversity of M channel properties (1). The M current (IM) is a subthreshold noninactivating voltage-dependent potassium current that is found in many neuronal cell types. The M current controls membrane excitability, and it has been shown to be modulated by a variety of intracellular signals that in turn dramatically affect the firing rate of neurons. Among those intracellular signals, Ca2+ has been shown to mediate the inhibition of IM by B2 bradykinin receptors in sympathetic neurons (3). Indeed, intracellular Ca2+ can suppress the activity of M channels under conditions that do not support enzymatic activities such as phosphorylation (4). This phenomenon suggests that an intermediary might be involved in this Ca2+-dependent modulation.

In a search for candidates that might mediate the effects of Ca2+ in modulating IM, we screened a human brain cDNA library using the yeast two-hybrid system. We found that calmodulin (CaM)1 bound to the C-terminal region of KCNQ channels. CaM is a small Ca2+-binding protein that acts as a ubiquitous intracellular Ca2+ sensor in the regulation of a growing diverse array of ion channels (5). Efforts to define common characteristics of CaM binding have indicated that it associates with short alpha -helical sequences within its targets (6-8). However, it appears that the interaction of CaM with KCNQ channels does not conform to this simple model. Rather, our data suggest that the CaM-binding site in KCNQ channels is formed by two alpha -helices that are separated by a stretch of ~130 amino acids. We hypothesize that those two helices come into close proximity in the tertiary structure, facilitating CaM binding.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Yeast Two-hybrid Analysis-- A cDNA generated by PCR encoding amino acids 310-844 of the human KCNQ2 subunit (9) was subcloned in frame with the GAL4 DNA-binding domain of the yeast vector pGBKT7 (CLONTECH) to be used as bait in a yeast two-hybrid screen. The reporter yeast strain Y190 was sequentially transformed with this plasmid and with a human brain cDNA library subcloned in pACT2 (CLONTECH, catalog number HL 4004 AH, lot 5008, mRNA source: normal, whole brain from a 37-year-old Caucasian male, whose probable cause of death was trauma). We screened >2.5 × 106 co-transformants that were selected on medium lacking histidine (in the presence of 25 mM 3-aminotriazole), leucine, and tryptophan and assayed for beta -galactosidase activity.

Constructs containing point mutations and deletions were generated by PCR as described previously (10), sequenced, and subcloned into pGBKT7 (CLONTECH bait vector). The mutated constructs were co-transformed, along with a rat CaM cDNA in pGADT7 (CLONTECH prey vector), into Y190 to asses their interaction in vivo. Yeast extracts were analyzed to confirm the presence of Myc-tagged bait proteins by Western blotting with the 9E10 monoclonal anti-c-Myc antibody. For liquid quantitative beta -galactosidase assays, O-nitrophenyl-beta -D-galactopyranoside was used as the substrate, and the number of beta -galactosidase units was calculated according to the CLONTECH protocol.

We also monitored the activity of the His reporter when using the low copy two-hybrid system, pPC97 and pPC86 (Invitrogen), with the yeast Y190 strain. Colonies growing in medium lacking leucine and tryptophan were grown in 1 ml of liquid medium overnight. The following morning the culture was diluted 100-fold in 10 mM Tris, 1 mM EDTA buffer and spotted on a Leu- Trp- His- plate with 10-50 mM 3-aminotriazole. After 2-4 days at 30 °C, the strength of the interaction was assessed by the size and color of the colonies.

In Vitro Binding and Western Blot-- Recombinant rat CaM was produced in BL21 Escherichia coli and purified as described (11). Different regions of human KCNQ subunits were generated by PCR, subcloned into the glutathione S-transferase (GST) fusion vector pGEX (Pharmacia Corp.) and transformed into BL21 E. coli. The synthesis of fusion proteins was induced with 0.5 mM isopropyl-beta -D-thiogalactopyranoside for 4 h at 30 °C. The cells were resuspended in chilled GST buffer that included protease inhibitors (20 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, pH 8, plus 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml each aprotinin and leupeptine) and lysed by sonication at 4 °C, and the protein was recovered by immobilization on glutathione-Sepharose 4B beads (Amersham Biosciences). After extensive washing, the immobilized proteins were equilibrated in pull-down buffer (25 mM Hepes, 120 mM KCl, 5 mM NaCl, pH 7.5) with either 2 mM CaCl2 or 5 mM EGTA. Rat calmodulin (10 µg) was added to the beads and incubated for 45 min at room temperature. After three washes, the proteins were recovered, separated by 15% SDS-PAGE in the presence of 5 mM EGTA, and transferred to Probond nitrocellulose (Schleicher & Schuell) for Western blotting. The nitrocellulose was blocked with 5% nonfat dry milk in 0.05% Tween 20 in phosphate-buffered saline, incubated with the primary antibody (monoclonal anti-CaM from Upstate, diluted 1:2000 in blocking buffer) overnight at 4 °C, washed, and incubated with horseradish peroxidase-conjugated goat anti-mouse IgG secondary antibody (Bio-Rad) diluted 1:5000 in blocking buffer. Antibody binding was detected using enhanced chemiluminiscence and ECL hyperfilm (Amersham Biosciences).

Antibody Production-- Divergent sequences from the intracellular N- and C-terminal regions of the different KCNQ channels were used to generate GST fusion proteins that were then used to produce antisera in rabbits. The specificity of the antisera produced was tested in immunoblots of membrane lysates of cells stably or transiently expressing different KCNQ subunits. A full description of the characterization of these antisera will be published elsewhere.2

Immunoprecipitation-- Stable (kindly provided by B. S. Jensen, NeuroSearch) or transient HEK293 cells expressing human KCNQ subunits were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum at 37 °C in 5% CO2. Transient expression was achieved with the KCNQ expression plasmid using LipofectAMINE 2000 (Invitrogen). For immunoprecipitation experiments, confluent 60-mm dishes were washed twice with ice-cold phosphate-buffered saline and solubilized for 1 h in 400 µl of immunoprecipitation buffer (50 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, pH 7.5) including protease inhibitors as above, and phosphatase inhibitors (1 mM NaF, 1 mM beta -glycerophosphate, and 5 mM pirophosphate). The cell lysates were centrifuged at 12,000 × g for 20 min to remove insoluble material, and the protein concentration was determined with the Bio-Rad protein assay. The lysate was diluted 10-fold in immunoprecipitation buffer, and bovine serum albumin was added to a final concentration of 1 mg/ml. Rabbit anti-KCNQ subunit-specific antibodies were added at 4 mg/ml and incubated for 3 h at 4 °C with agitation. Immunocomplexes were recovered with 40 µl of equilibrated protein A-agarose (Santa Cruz) and washed with immunoprecipitation buffer. The proteins were eluted in Laemmli's buffer and resolved in 8% SDS-PAGE for the channels or 15% SDS-PAGE for CaM. The rabbit antisera to KCNQ channels were used at 1:500 dilution, and the peroxidase-conjugated protein A/G (Pierce) was used at 1:5000 dilution.

Fluorimetric Determination of CaM Binding-- CaM (100 µl at 10 mg/ml) was diluted 10-fold in 100 mM Tris-HCl, 20 mM CaCl2, pH 8.5. Dansyl chloride dissolved in acetone (2.17 mg/ml) was added (12.5 µl) to achieve a final concentration of 100 µM. The mixture was incubated at room temperature in the dark for 2 h, vortexing every 20 min. Unincorporated dansyl was eliminated using a 1-ml G-25 Sepharose column. The concentration of dansyl-calmodulin used in all experiments was 200 nM, unless noted otherwise.

Fluorescence spectra were recorded in a Perkin-Elmer fluorescence spectrophotometer in a final volume of 3 ml (light path, 1 cm). Dansyl-CaM was diluted in binding buffer (25 mM Tris-HCl, 120 mM KCl, 5 mM NaCl, with either 5 mM EGTA or 2 mM Ca2+, pH 7.4). The excitation wavelength was 340 nm, and the emissions were collected from 450 to 600 nm (0.5-nm steps).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

CaM Interacts with the Intracellular C-terminal Region of KCNQ Channels-- Potassium channels that are members of the KCNQ protein family have been implicated in pathological conditions affecting the nervous system and in the physiological regulation of excitable cells. Indeed, the activity of channels containing KCNQ subunits can affect aspects of the behavior of the cell as important as their firing rate. To identify proteins capable of modulating the activity of these channels, we have performed a yeast two-hybrid screen of a human brain cDNA library using the intracellular C-terminal region of human-KCNQ2 as bait (534 amino acids).

We identified 32 positive clones that grew in the absence of histidine (25 mM 3-aminotriazole added), leucine, and tryptophan and that presented beta -galactosidase activity. Of these, 19 clones were identified as the product of the gene CALM2, and 13 clones were identified as the product of the gene CALM3. Both genes encode variants of CaM and have an identical amino acid sequence. This interaction was confirmed in a second assay where CaM was used as bait and the C-terminal region of KCNQ2 or KCNQ3 was used as prey, demonstrating that the association of CaM with KCNQ subunits was independent of which protein is fused to the binding or activation domain.

Other regions of the KCNQ2 intracellular domain were also studied to determine whether they too were capable of interacting with CaM. We tested the N-terminal region (Met1-Arg89), the loop connecting the second and third transmembrane domains (Arg144-Ile173), and the loop connecting the fourth and fifth transmembrane domain (Leu206-Ala235). We also tested the pore region (Glu254-Leu292) that connects the fifth and sixth transmembrane domains because an interaction of the equivalent region of KCNQ1 with the C-terminal region of minK has been demonstrated in the two-hybrid assay (12). We were unable to observe any interaction between the constructs encoding these regions and CaM in the two-hybrid assay, despite the detection of these Myc-tagged hybrid proteins in immunoblots of lysates from transformed yeast (not shown).

The C-terminal domain of KCNQ channels commences with a region that is highly conserved between several members of this family and that is followed by a more divergent region. To study the domain to which CaM binds in more detail, we divided the C-terminal region of KCNQ2 and KCNQ3 into two overlapping parts and found that CaM interacted only with the initial, more highly conserved region (see Fig. 2). The overall similarity of this initial C-terminal region as defined by the Clustal method of DNA-Star software ranges from 38 to 45% for KCNQ2-5 subunits, and the similarity between KCNQ1 and the other KCNQ channels ranges from 22 to 25%. Using this C-terminal region as bait (or the whole C-terminal region; not shown), we found that each member of the KCNQ channel family was capable of interacting with CaM. Furthermore, when the interaction was quantified with a liquid beta -galactosidase assay, the binding of CaM appeared to be stronger for the KCNQ1 and KCNQ3 C-terminal regions than for those of KCNQ2, KCNQ4, or KCNQ5. The values relative to the quantification obtained with KCNQ1 (aa 250-456, n >=  5) were 48.7 ± 3.3% for KCNQ2 (aa 310-550), 150.0 ± 14.8% for KCNQ3 (aa 349-556), 22.1 ± 2.7% for KCNQ4 (aa 316-571), and 77.7 ± 24.6% for KCNQ5 (aa 309-524). The significance of these differences remains unclear.

CaM Interacts with Full-length KCNQ Channels-- To determine whether CaM associates directly with full-length channels inserted into the membrane, we immunoprecipitated KCNQ2 from solubilized membranes of transiently transfected HEK293T cells. A ~20-kDa band was recognized by a CaM-specific antibody in the immunoprecipitate obtained in Ca2+-free conditions with antisera to the KCNQ2 subunits but not with preimmune serum (Fig. 1). In the presence of calcium, CaM was also co-immunoprecipitated, although the amount that could be detected was reduced.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   CaM and KCNQ2, KCNQ3, or KCNQ5 co-immunoprecipitate from transfected cells. Membrane preparations from HEK293T cells transiently expressing KCNQ2 or stably expressing KCNQ3 or KCNQ5 subunits were solubilized and immunoprecipitated in the absence (-) or presence (+) of Ca2+ (with the addition of 5 mM EGTA or 2 mM Ca2+, respectively). The immunoprecipitations were performed with antisera raised against a fusion protein of the N-terminal region of KCNQ2 (alpha -KN2), the C-tail of KCNQ3 (alpha -KC3), or the N terminus of KCNQ5 (alpha -KN5). The precipitated proteins were resolved in 8 or 15% polyacrylamide denaturing gels, and the channels or CaM were then detected by Western blotting. The association between CaM and KCNQ subunits was more clearly detected in lysates processed in the absence of Ca2+. C, control lysate; pI, preimmune serum. Molecular masses in kDa are indicated on the left of the figure.

When specific antisera were used to immunoprecipitate KCNQ3 and KCNQ5 from solubilized membranes of stable HEK293 cell lines expressing these subunits,2 CaM was present in the immunoprecipitate in Ca2+-free conditions. As for KCNQ2, in the presence of Ca2+, less CaM appeared to be associated with these subunits (Fig. 1). Moreover, no CaM was detected when preimmune antisera were used. Thus, we concluded that native neuronal KCNQ channels interact preferentially with apo-CaM.

Mapping of the KCNQ Regions Necessary for the Interaction with CaM-- Extensive studies have shown that CaM binds to amphipatic alpha -helices (6-8). To detect potential alpha -helices within the C-terminal region of KCNQ channels, we used two secondary structure prediction algorithms (GOR4 and Predator; www.expasy). These algorithms highlighted four regions with a high probability of forming an alpha -helix in several members of the KCNQ channel family (Fig. 2B, helices A-D). Helix D corresponds to the putative assembly domain (13, but see Ref. 14), and helix C corresponds to the A domain (15). We tested the capacity of all of these potential alpha -helical domains to interact with CaM using the high copy plasmid two-hybrid CLONTECH system (pGBKT7 bait, pGADT7 prey). Although the proximal C-terminal region (that include helices A and B) interacted with CaM, distal regions including helices B, C, and D did not (Fig. 2C). Similarly, a region including helix A (Gly310-Ser448) or helix B and part of helix C (Ser448-Asp549) did not bind CaM. We next performed a series of lateral and internal deletions in the KCNQ2 C-terminal amino acid sequence. As a result of analyzing these deletions, we determined that the binding of CaM required the simultaneous presence of two discontinuous regions (helix A (Gly310-Tyr372) and helix B (Thr501-Glu529); Fig. 2C).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Helices A and B are required for CaM interactions. A, schematic topological representation of KCNQ channels. B, probability of alpha -helix content of the C-terminal region of KCNQ channels using the Predator algorithm (filled symbols) or GOR4 algorithm (open symbols). The C-terminal region of the five known members of the KCNQ family have being aligned using the Clustal method (DNAstar software). At some positions the program introduced gaps in one or more sequences. The average score at the positions where none of the five sequences presented a gap are displayed, highlighting four regions (helices A-D) with a high alpha -helix content probability. C, schematic representation of the constructs in the C-terminal region that were analyzed for their interaction with CaM. Constructs that did not interact with CaM are represented in black. The production of the Myc-tagged bait protein was verified by Western blot using an anti-Myc antibody. The shaded boxes indicate the two regions required for interaction with CaM.

Several consensus sites for CaM binding have already been described (6, 7). A closer analysis of the region that contains helix A showed that it includes a sequence that resembles the IQ CaM binding motif and that this is conserved among several members of the KCNQ family (Fig. 3A). Mutations within the IQ motif have been shown to abolish the interaction between CaM and neurogranin in a two-hybrid assay (16) or to alter the Ca2+-dependent regulation of ion channels (17). We introduced several point mutations to determine whether amino acids within the IQ domain are necessary for the interaction of KCNQ2 with CaM. These mutations included Ile340 right-arrow Ala, Ile340 right-arrow Glu, Ser342 right-arrow Asp, and Ala343 right-arrow Asp.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Identification of key residues for CaM binding using the two-hybrid assay. A, alignment of helix A of KCNQ channels with the IQ-binding motif. B, the effect of point mutations of key residues on CaM binding. C, alignment of helix B of KCNQ channels indicating two overlapping 1-5-10 CaM binding motifs. D, the effect of Ser right-arrow Asp mutations at the positions indicated of KCNQ2-BD on CaM binding. E, representative examples of the growth of yeast co-transformed with the indicated KCNQ C-tail mutants. WT, wild type scores; +, pale blue signal in the beta -galactosidase assay; -, no detectable blue signal.

Amino acid alignment of the IQ motifs indicates that Ala343 of KCNQ2 corresponds to Ser36 of neurogranin (not shown). Mutating Ser36 right-arrow Ala of neurogranin makes the IQ motif of neurogranin resemble that of KCNQ2 and does not affect (or may even increase) CaM binding. However, mutating Ser36 right-arrow Asp, thereby introducing a negative charge that mimics the effect of protein kinase C, abolishes the interaction between neurogranin and CaM in the two-hybrid assay (16). Similarly, we found that the interaction between CaM and the KCNQ2 bait was lost in the equivalent Ala343 right-arrow Asp mutant. The interaction was also disturbed when the Ile340 right-arrow Ala and Ile340 right-arrow Glu mutations were introduced, and the Ser342 right-arrow Asp mutation appeared to partially perturb CaM binding because the filter beta -galactosidase assay took longer to develop and gave a weaker signal (Fig. 3E). Thus, it appears that the IQ binding motif is necessary to sustain CaM binding in the yeast two-hybrid assay.

Helix B contains two overlapping 1-5-10 CaM binding motifs (Fig. 3C and Ref. 7). We determined whether the introduction of negative charges in this region affected CaM binding in a manner similar to that used when they are introduced into key positions of the IQ binding motif. Within helix B of KCNQ2 there are three protein kinase C phosphorylation consensus sites (Ser511, Ser523, and Ser530), and thus we investigated the effect of introducing a negative charge (mutating Ser right-arrow Asp) at these positions to mimic the effect of phosphorylation. We also evaluated the effect of mutating serine 406, which is also a potential target for protein kinase C but that lies in a region not required for CaM binding. As expected, the introduction of an aspartate at position 406 did not alter CaM binding (not shown). In contrast, the interaction with CaM was lost when serine 511 was mutated to aspartate (Ser511 right-arrow Asp) but appeared to be only slightly affected (the signal was fainter than for the wild type) when the other serine residues were mutated (Fig. 3, D and E). These results suggest that protein kinase C might regulate the binding of CaM to KCNQ2 channels through the phosphorylation of Ser511.

To further characterize the interaction between CaM and the KCNQ channels, we performed GST pull-down experiments (Fig. 4). Different fragments of the C-terminal region of KCNQ2 were fused in frame to GST, and their binding to apo-CaM and Ca2+-CaM was compared with that of GST-neurogranin and GST fused to the C-terminal region of the NR1 subunit (18). The association of purified recombinant rat CaM to fusion proteins was analyzed both in the absence and in the presence of Ca2+. Western blots probed with a monoclonal anti-CaM antibody showed that the fragments including helix A (aa 310-451) or helix B (aa 445-548) bound CaM in the presence of Ca2+ (Fig. 4). In the absence of Ca2+, helix A did not bind CaM, whereas helix B appeared to show a weak interaction with CaM. In the two-hybrid assay, both of these regions appeared to be incapable of interacting with CaM; however, as discussed later, this can be explained by the failure to detect interactions with Ca2+-CaM with the two-hybrid assay.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 4.   GST pull-down experiments. GST fusion proteins of the A, B, or AB domains were tested for their ability to interact with CaM in the absence (5 mM EGTA) or presence (2 mM Ca2+) of Ca2+. GST-neurogranin (Nrg, aa 1-78) and GST-NR1 (fused to the C0C1C2 C-terminal region of the NR1 receptor, aa 818-922) were used as positive controls to demonstrate interactions with apo-CaM and Ca2+-CaM, respectively. Domains A and B bound CaM much better in the presence than in the absence of Ca2+, whereas domain AB bound CaM better in the absence of Ca2+.

A GST fusion protein containing the most C-terminal region of KCNQ2 (aa 549-844) was incapable of binding CaM in either the presence or the absence of Ca2+. In contrast, CaM was pulled down independently of the presence of Ca2+ (although more CaM was pulled down in absence of Ca2+) when the GST fusion included a fragment that contained helices A and B (aa 310-548; Fig. 4), again indicating that CaM interacts directly with KCNQ channels.

The interaction of CaM with the C-terminal tail of KCNQ2 was studied by fluorimetry (Fig. 5). The fluorescence spectrum of CaM dansylated at Lys75 is shifted, and the intensity increases when the environment of the fluorophore becomes hydrophobic (19). Dansyl-CaM was incubated with GST, GST-helix A, GST-helix B, or GST-helices A+B fusion proteins, and the changes in fluorescence emission induced by the interaction were studied in the presence (2 mM Ca2+) and absence of Ca2+ (in the presence of 5 mM EGTA). As previously shown, GST alone had no effect on the emission spectrum of dansyl-CaM independent of the [Ca2+] (20). In the presence of Ca2+ and equimolar concentrations of the GST fusion proteins that included helices A and B or helix B alone, modest changes in the fluorescent emission were detected. These changes were even more modest in the presence of the GST-helix A fusion protein. In contrast, a substantial enhancement in fluorescence was observed in the absence of Ca2+ with the GST-helices A+B fusion protein. Using a series of dansyl-CaM concentrations (50-400 nM), the EC50 estimated in the absence of Ca2+ for GST-AB binding to dansyl-CaM ranged from 186 to 320 nM. Under similar conditions, the change in fluorescence remained modest with the GST-helix B fusion and could not be detected with the GST-helix A fusion. In addition, no synergism was seen in the enhancement of fluorescent emission when both GST-helix B and GST-helix A were used together. Thus, the most significant changes in fluorescence were seen when both helices are part of the same polypeptide, suggesting that in the absence of Ca2+, this peptide folds in such a way that it provides a better CaM-binding site than helix B alone (Fig. 5).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 5.   Changes in dansyl-CaM fluorescence induced by GST-Helix A, GST-Helix B, and GST-Helices A+B. Emission spectrum of dansyl-CaM (200 nM) alone and when mixed with GST fusion proteins in the absence (A) and presence of Ca2+ (B) is shown. The fluorescence spectrum of dansyl-CaM was determined upon excitation at 340 nm.

The role of helices A and B was further examined by transiently expressing in HEK cells mutant KCNQ2 channels in which the helices were deleted and assessing their ability to associate with CaM by immunoprecipitation. CaM was not co-immunoprecipitated by antisera against KCNQ2 in cells expressing mutants devoid of helix A (Delta IQ Leu339-Thr358, Delta pIQ Trp359-Met371), helix B (Delta Phi Ser511-Ser523), or both (Delta IQ+Delta Phi ; Fig. 6). In contrast, the deletion of aa 372-493 did not appreciably inhibit CaM binding (Fig. 6A). In addition, we analyzed the point mutant Ser342 right-arrow Asp, which gave a weak signal in two-hybrid assay (Fig. 3E). With this mutant, CaM was only seen to co-immunoprecipitate with the channel in the absence of Ca2+. In contrast, the association of CaM was not observed with the Ser511 right-arrow Asp mutant in the presence or absence of Ca2+. Thus, the results of the co-immunoprecipitation experiments paralleled those obtained in the two-hybrid assay, reinforcing the proposal that both helices are necessary for interaction with CaM in the intact channel.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Co-immunoprecipitation of KCNQ2 deletion mutants. A, membrane preparations from HEK293T cells transiently expressing KCNQ2 mutants were solubilized and immunoprecipitated with alpha -KN2 antisera in the absence (-) or presence (+) of Ca2+ (with the addition of 5 mM EGTA or 2 mM Ca2+, respectively). The precipitated proteins were resolved in 8 or 15% polyacrylamide denaturing gels to detect the channels or CaM by Western blotting, respectively. The association between CaM and Delta IQ, Delta pIQ, and Delta Phi was detected neither in the presence nor the absence of Ca2+ condition. The deleted amino acids were: Delta IQ L339-T358, Delta pIQ W359-M371, and Delta Phi S511-S523. B, CaM was co-immunoprecipitated with the Ser342 right-arrow Asp in the absence of Ca2+, but an interaction was not detected with the Ser511 right-arrow Asp mutant in any Ca2+ condition. WT, wild type.

Determinants in CaM That Are Required for Binding to KCNQ-- CaM is composed of four Ca2+-binding helix-loop-helix motifs, called EF hands. These are arranged in two pairs, each pair forming a distinct domain or lobe. The domains are arranged in a dumbbell-like conformation at the ends of a flexible central helix (aa 65-92). The N-terminal lobe (aa 1-77) contains EF hands 1 and 2, and the C-terminal lobe (aa 78-148) contains EF hands 3 and 4. It is thought that, in evolutionary terms, CaM arose by duplication of a gene that represented one lobe. As a consequence EF hands 1 and 3 are alike, and EF hand 2 is most similar to EF hand 4 (8). Ca2+ binds to the four EF hand motifs in a highly cooperative manner. First it associates with EF hands 4 and 3, and subsequently it associates with EF hands 2 and 1. The binding of Ca2+ to the EF hands results in the creation of a surface that serves as an interface for the association of CaM with the target protein. Each lobe can control distinct processes in the target protein (21, 22), and binding to a target can change the affinity for Ca2+ (23).

To investigate the role of the different EF hands, we studied the interaction of a mutated CaM where the first aspartate of EF hands 2, 3, and 4 has been replaced with alanine and another CaM mutated at EF hands 3 and 4. These Asp to Ala mutations in the EF hands greatly diminish or abolish their ability to bind Ca2+ (21, 24, 25). Both mutants were able to interact with the C-terminal region of KCNQ2 or KCNQ3, although less strongly than wild type CaM. In the liquid galactosidase assay the intensity of the signal obtained with the EF-2,3,4 mutant was ~40% of wild type CaM (not shown, but see Fig. 7C).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 7.   CaM domains involved in binding to KCNQ channels. A, the two-hybrid binding assay detected an interaction of CaM with targets known to interact with apo-CaM (C-terminal region of SK2) as well as for the C terminus of KCNQ2, KCNQ3, and P/Q voltage-dependent calcium channels. No interaction was seen for targets known to interact with Ca2+-CaM (C-terminal region of the NMDA receptor (C0C1C2), the CaM-binding region of myosin light chain kinase), or the C-terminal region of Eag voltage-dependent potassium channels. The regions used were: SK2, 390-707; KCNQ2, 510-550; neurogranin (Nrg), 1-78; P/Q, 1761-2213; NR1, 815-922; Eag, 666-1307; and myosin light chain kinase (MLCK), 959-1332. B, full-length CaM was required for binding to KCNQ channels. The fragments of CaM indicated were tested for interaction with KCNQ2-BD and KCNQ3-BD. The whole C-terminal region of SK2 was used as a positive control. The CaM fragments tested were: EF12, 1-82; EF34, 78-148; EF123, 1-132; EF234, 42-148; EF1, 1-46; and EF4, 109-148. C, EF hand 1 (and EF hand 3 to a lesser degree) is important for the interaction of CaM with KCNQ2-BD in the two-hybrid assay. The interaction of CaM with an Asp right-arrow Ala mutation at the indicated EF hands was tested in the two-hybrid assay. D, scores of interaction with the different EF hand mutants. +, growth in His- medium but without a clear blue signal in the beta -galactosidase assay; +++, strong beta -galactosidase signal.

The determinants for this interaction were further studied using the low copy number pPC97 (bait) and pPC86 (prey-CaM) vectors. These plasmids produce more physiological levels of protein than the ones used to perform the previous experiments. Thus, this low copy number system allows for better discrimination of small changes in binding strength caused by the point mutations introduced into either the bait or the prey. It has been proposed that this two-hybrid assay only detects Ca2+-independent interactions with CaM (21). While this still remains unclear (26), this may be an important technical consideration to bear in mind given the difficulties encountered in identifying the site of interaction of apo-CaM to some proteins (27). As mentioned earlier, we found that in vitro, helix A and helix B can associate with Ca2+-CaM (Fig. 4), although we were unable to detect this interaction in vivo with the two-hybrid assay. This is in keeping with Keen's proposal (21). Moreover, using this assay, we were unable to detect an interaction of CaM with baits known to interact with Ca2+-CaM but not with apo-CaM (baits such as the C-terminal region of the NMDA receptor (18); the Eag potassium channel (28); and the CaM binding site of myosin light chain kinase (7)). Conversely, when neurogranin, which binds to apo-CaM but not to Ca2+-CaM, was used (7), a clear interaction could be seen (Fig. 7A).

We tested fragments of CaM to determine which regions were required for binding to KCNQ2 and to KCNQ3 (Fig. 7B). We also studied the interaction of CaM with the full C-terminal region of SK2 potassium channel as well as neurogranin and the C-terminal region of P/Q calcium channel for reference (16, 21, 29). As previously reported, we found that the C-terminal lobe of CaM (aa 78-148, EF-3,4) interacted with the C-terminal domain of SK2 (21). In contrast, full-length CaM (i.e. the four EF hands) was required to bind to the C-terminal AB region of KCNQ2 or KCNQ3 subunits.

CaM carrying different combinations of EF hands mutated at the first aspartate were tested for their ability to associate with the AB region of KCNQ2 (Fig. 7C). Although apo-CaM binds to both the SK (25) and KCNQ family of channels, there is no significant sequence homology in the C-terminal region of these K+ channels. It has been reported that CaM carrying mutations in any or all combinations of the EF hands associates with a fragment of the C-terminal region of SK2 (aa 390-487) (21). In the experiments reported here we used a longer bait (aa 390-707) that produced a weaker signal (i.e. the strength of the interaction of the hybrid proteins is closer to the threshold level of detection). With the full C-terminal region of SK2, the assay produced a signal that was difficult to detect when either EF hands 3 or 4 were mutated alone or in combination (M3, M4, and M34). Because it has been clearly demonstrated that EF hands 3 and 4 directly mediate the interaction of apo-CaM with SK2 channels (21, 23), these results indicate that the strength of binding is reduced when Asp right-arrow Ala mutations are introduced into these EF hands, sometimes to below the threshold of detection.

In contrast to SK, the interaction with the KCNQ2 or KCNQ3-AB region was lost or deficient when EF hands 1 or 3 were mutated (M1, M3, and M13), suggesting that these EF hands directly mediate the interaction of apo-CaM with KCNQ channels. In addition, the complementary M1 and M3 mutants (M234 and M124) retained the ability to interact with the KCNQ-AB region. Interestingly, whereas M1 did not bind to the KCNQ-AB region, the interaction was partially recovered when EF hands 1 and 2 were mutated simultaneously (M12 and M124), suggesting the existence of important cross-talk between EF hands 1 and 2 that influences the binding of CaM to KCNQ channels. Similarly, the interaction was recovered when EF hands 1 and 4 were mutated simultaneously (M14 and M124), indicating that both CaM lobes are functionally interconnected when interacting with the KCNQ-AB region.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have demonstrated here that CaM binds to the intracellular C-terminal domain of neuronal KCNQ2, KCNQ3, and KCNQ5 transmembrane channels. Two-hybrid experiments suggest that CaM also binds to KCNQ1 and KCNQ4, but more experiments are necessary to unequivocally confirm this interaction. The voltage-dependent channels to which members of this family of proteins contribute have been implicated in a variety of physiological processes and pathologies. As a result, the modulation of the activity of these channels through intracellular signaling is important in maintaining the physiological homeostasis of nervous tissue (30). An example of this can be seen in the Ca2+-dependent regulation of M channels (made up of KCNQ subunits) that influences the firing rate of the sympathetic cells in which they are expressed. Our results indicate that through its association with these proteins, CaM may mediate the Ca2+-dependent modulation of channels that include KCNQ subunits.

In addition to demonstrating here that CaM associates with members of the KCNQ family, we have also defined its binding site. The binding site identified in this study is unusual in that it is composed of two discontinuous regions, helix A and helix B. Helix A contains an IQ-like binding motif, a motif (IQXXXRXXXXR) that mediates apo-CaM binding in a variety of proteins (31) and that contains positively charged residues at positions 6 and 11. When compared with other IQ motifs, in the helix A of the KCNQ channels the second Arg is replaced by a negatively charged or neutral amino acid. As a result, this domain resembles the second "incomplete" IQ motif on myosin II, the region to which the regulatory myosin light chain (structurally similar to CaM) binds. A model of apo-CaM binding derived from this and other light chain structures bound to myosin IQ motifs reveals that the initial portion of this motif (IQXXXR) is the most critical part. Moreover, it is this region that is specifically recognized by the loop between EF hands 3 and 4 and that determines a semi-open lobe conformation (32). In accordance with this model, the interaction of KCNQ2 with CaM is destabilized when point mutations are introduced in this first part of the IQ motif.

On many occasions, the C lobe of CaM has been shown to be that which interacts with peptides, as also occurs with CaM-like proteins that associate with peptides. Moreover, the bound peptide essentially occupies the same position relative to the C-terminal EF hand domain (33). The finding that the C lobe is sufficient to bind to SK channels (21), P/Q Ca2+ channels, and neurogranin supports this finding. However, in contrast, it appears that to bind to KCNQ2 or KCNQ3 channels, both the C and N lobes are required.

Surprisingly, we found that when using the full-length C-terminal region of SK2 as bait, point mutations that abolish Ca2+ binding to EF hands 3 or 4 also abrogate the interaction with CaM. There is, however, ample biochemical, functional, and structural evidence to indicate that Ca2+ is not bound to EF hands 3 or 4 when CaM interacts with SK2. In addition, it has been shown that the Ca2+-free C-terminal lobe is that which mediates the binding of CaM to the SK2 CaM-binding domain (21, 23). Our results indicate that mutating the first aspartate to alanine in the EF hands that directly mediate the interaction of apo-CaM with the target causes a reduction in the binding strength. By analogy with the SK2 CaM-binding domain, the observation that the interaction of CaM with KCNQ2 or KCNQ3 does not tolerate point mutations at EF hand 1 and (to a lesser degree) 3 suggests that binding to the KCNQ-BD is mainly mediated by the apo-EF hands 1 and 3. Interestingly, EF hand 1 is most similar to EF hand 3 (8), suggesting that both play a similar role in stabilizing the target complex.

The difficulties in identifying apo-CaM interactions have been highlighted by Erickson et al. (27). To overcome this problem, a very elegant technique has been developed, three-cube fluorescence resonance energy transfer, that demonstrates the preassociation of CaM with calcium channels in living cells (27). The yeast two-hybrid system is another viable alternative for approaching this problem. Our results provide further evidence that the two-hybrid assay is capable of detecting interactions between the Ca2+-free form of CaM and target proteins such as the SK2 K+ channels (21). It should be born in mind that a limitation of the two-hybrid system is that the transmembrane segments of target proteins must be eliminated to allow targeting of the bait to the nucleus (34). However, the main advantage is that this is a relatively simple assay and that it does offer us the opportunity to study protein-protein interactions in a living cell (16).

The recent resolution of the structure of CaM associated with the SK-binding domain has shown that the binding domain is composed of two alpha -helices connected by a short loop (23). The high probability that the two KCNQ regions contain alpha -helices suggests that a similar conformation to the SK2 CaM-binding domain may also arise in KCNQ. However, some differences are evident. Although in SK channels the connecting loop is only 5 aa long, in KCNQ channels this varies from ~100 to ~150 aa. Secondly, the C lobe of CaM (EF hands 3 and 4) is sufficient for binding to SK channels (21), whereas the complete CaM molecule is necessary for binding to KCNQ2 or KCNQ3 channels. In essence, our data suggests that the C-terminal domain of KCNQ channels folds in such a way that helix A and helix B form a compact structure that can be engulfed between the N- and C-terminal lobes of apo-CaM (Fig. 8).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 8.   Model of the interaction of CaM with KCNQ channels. The main features of the model are that helix A and helix B come into close proximity in the tertiary structure and are engulfed by CaM. The S6 transmembrane segment and pore region of only two subunits of a tetrameric potassium channel are shown for clarity. The relative orientation of helix A of the two subunits is a suggestion based on the proposed structure of cyclic nucleotide gated channels (36). The crystal structure of KcsA potassium channel (S6 and pore) (39) and the crystal structure of the SK potassium channel binding domain complexed with CaM (23) have been used as templates to draw this cartoon to scale.

What is the role of CaM in KCNQ function? The preassociation of apo-CaM to a target protein whose activity may be regulated by CaM generally ensures a rapid and selective response to local elevations in Ca2+ (8, 27). Indeed, the suppression of the M current by bradykinin in rat sympathetic neurons is mediated by this cation (3), and apo-CaM has been shown to modulate the Ca2+-dependent gating of many channels (27, 35). The Ca2+-dependent modulation of M channels can also be observed in excised patches. Under these conditions, signaling pathways such as phosphorylation are not supported, and because the effects observed are fully reversible, it becomes very unlikely that the modulation of IM via Ca2+ is due to dephosphorylation of the M channel or of an associated protein. Furthermore, the absence of a "signature" flickering behavior and the tendency to "desensitize" in inside-out patches (i.e. the effect is transient) suggests that the activity of Ca2+ does not involve the direct blockage of the internal mouth of the channel (4). These observations indicate that the mediator exists in limited amounts in excised patches and that it is washed out after the application of Ca2+. These properties suggest the involvement of a Ca2+ sensor such as CaM, which, as we have shown, interacts with the C-terminal intracellular region of KCNQ channels. In this respect, it is interesting to reflect on the fact that helix A is adjacent to the end of S6, the last transmembrane domain (Fig. 8). In other channels with a similar six transmembrane architecture, such as SK Ca2+-activated K+ channels and cyclic nucleotide-gated channels, gating is modulated by a module that attaches to the end of S6 (23, 36). However, we should also bear in mind that the binding of CaM may also be important in other processes such as assembly or trafficking (37, 38). The functional analysis of mutants unable to bind CaM should help to unveil the role of CaM in KCNQ channel function.

    ACKNOWLEDGEMENTS

We are very grateful to Drs. J. Maylie (Oregon Health Sciences University), T. Jentsch (Zentrum für Molekulare Neurobiologie Hamburg, Hamburg, Germany), L. M. Pardo and W. Stühmer (Max Planck Institute, Göttingen, Germany), A. Villalobo and J. Bernal (Instituto de Investigaciones Biologicas-Consejo Superior de Investigaciones Cientificas, Madrid, Spain), W. A. Catterall (University of Washington), B. J. Jensen (NeuroSearch, Ballerup, Denmark), V. I. Teichberg (Weizmann Institute of Science, Rehovot, Israel), J. T. Stull (University of Texas Southwestern Medical Center, Dallas, TX), and S. Pons (I Cajal, Madrid, Spain) for providing us with cDNAs and other materials used in this study. We thank Dr. Paula Bosch and Dr. Fernando Diaz for providing equipment and help in the fluorimetric assays. We acknowledge the help of Dr. Fernando Moro and Dr. M. Paz Regalado in some parts of the project, Dr. Mark Sefton for critical comments on the manuscript and editorial help, and Carmen Page and Uyen Le for technical assistance.

    FOOTNOTES

* This work was supported by European Union Grant QLGT-1999-00827, Fondo de Investigaciones Sanitarias Grant FIS01/1136), Comunidad de Madrid Grant 08.5/0011/2001.1, and Spanish Ministry of Education Grant SAF2000-0159).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 34-91-585-4718; Fax: 34-91-585-4754; E-mail: av@cajal.csic.es.

Published, JBC Papers in Press, May 24, 2002, DOI 10.1074/jbc.M204130200

2 E. Yus-Nájera, A. Muñoz, J. DeFelipe, and A. Villaroel, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: CaM, calmodulin; apo-CaM, apo-calmodulin, Ca2+-free calmodulin; Ca2+-CaM, Ca2+-bound calmodulin; IQ, calmodulin binding motif; GST, glutathione S-transferase; dansyl, 5-dimethylaminonaphthalene-1-sulfonyl; aa, amino acid(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Jentsch, T. J. (2000) Nat. Rev. Neurosci. 1, 21-30[CrossRef][Medline] [Order article via Infotrieve]
2. Wang, H. S., Pan, Z., Shi, W., Brown, B. S., Wymore, R. S., Cohen, I. S., Dixon, J. E., and McKinnon, D. (1998) Science 282, 1890-1893[Abstract/Free Full Text]
3. Cruzblanca, H., Koh, D. S., and Hille, B. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7151-7156[Abstract/Free Full Text]
4. Selyanko, A. A., and Brown, D. A. (1996) Neuron 16, 151-162[CrossRef][Medline] [Order article via Infotrieve]
5. Saimi, Y., and Kung, C. (2002) Annu. Rev. Physiol. 64, 289-311[CrossRef][Medline] [Order article via Infotrieve]
6. O'Neil, K. T., and DeGrado, W. F. (1990) Trends Biochem. Sci. 15, 59-64[CrossRef][Medline] [Order article via Infotrieve]
7. Rhoads, A. R., and Friedberg, F. (1997) FASEB J. 11, 331-340[Abstract]
8. Jurado, L. A., Chockalingam, P. S., and Jarrett, H. W. (1999) Physiol. Rev. 79, 661-682[Abstract/Free Full Text]
9. Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., and Steinlein, O. K. (1998) Science 279, 403-406[Abstract/Free Full Text]
10. Villarroel, A., and Regalado, M. P. (1997) Trends Genet. 13, 164[CrossRef]
11. Hayashi, N., Matsubara, M., Takasaki, A., Titani, K., and Taniguchi, H. (1998) Protein Expression Purif. 12, 25-28[CrossRef][Medline] [Order article via Infotrieve]
12. Romey, G., Attali, B., Chouabe, C., Abitbol, I., Guillemare, E., Barhanin, J., and Lazdunski, M. (1997) J. Biol. Chem. 272, 16713-16716[Abstract/Free Full Text]
13. Schmitt, N., Schwarz, M., Peretz, A., Abitbol, I., Attali, B., and Pongs, O. (2000) EMBO J. 19, 332-340[CrossRef][Medline] [Order article via Infotrieve]
14. Smith, J. S., Iannotti, C. A., Dargis, P., Christian, E. P., and Aiyar, J. (2001) J. Neurosci. 21, 1096-1103[Abstract/Free Full Text]
15. Schwake, M., Pusch, M., Kharkovets, T., and Jentsch, T. J. (2000) J. Biol. Chem. 275, 13343-13348[Abstract/Free Full Text]
16. Prichard, L., Deloulme, J. C., and Storm, D. R. (1999) J. Biol. Chem. 274, 7689-7694[Abstract/Free Full Text]
17. Zühlke, R. D., Pitt, G. S., Deisseroth, K., Tsien, R. W., and Reuter, H. (1999) Nature 399, 159-162[CrossRef][Medline] [Order article via Infotrieve]
18. Ehlers, M. D., Zhang, S., Bernhadt, J. P., and Huganir, R. L. (1996) Cell 84, 745-755[CrossRef][Medline] [Order article via Infotrieve]
19. Mori, M., Konno, T., Ozawa, T., Murata, M., Imoto, K., and Nagayama, K. (2000) Biochemistry 39, 1316-1323[CrossRef][Medline] [Order article via Infotrieve]
20. El Far, O., Bofill-Cardona, E., Airas, J. M., O'Connor, V., Boehm, S., Freissmuth, M., Nanoff, C., and Betz, H. (2001) J. Biol. Chem. 276, 30662-30669[Abstract/Free Full Text]
21. Keen, J. E., Khawaled, R., Farrens, D. L., Neelands, T., Rivard, A., Bond, C. T., Janowsky, A., Fakler, B., Adelman, J. P., and Maylie, J. (1999) J. Neurosci. 19, 8830-8838[Abstract/Free Full Text]
22. DeMaria, C. D., Soong, T. W., Alseikhan, B. A., Alvania, R. S., and Yue, D. T. (2001) Nature 411, 484-489[CrossRef][Medline] [Order article via Infotrieve]
23. Schumacher, M. A., Rivard, A. F., Bachinger, H. P., and Adelman, J. P. (2001) Nature 410, 1120-1124[CrossRef][Medline] [Order article via Infotrieve]
24. Geiser, J. R., van Tuinen, D., Brockerhoff, S. E., Neff, M. M., and Davis, T. N. (1991) Cell 65, 949-959[CrossRef][Medline] [Order article via Infotrieve]
25. Xia, X. M., Fakler, B., Rivard, A., Wayman, G., Johnson-Pais, T., Keen, J. E., Ishii, T., Hirschberg, B., Bond, C. T., Lutsenko, S., Maylie, J., and Adelman, J. P. (1998) Nature 395, 503-507[CrossRef][Medline] [Order article via Infotrieve]
26. Hisatsune, C., Umemori, H., Inoue, T., Michikawa, T., Kohda, K., Mikoshiba, K., and Yamamoto, T. (1997) J. Biol. Chem. 272, 20805-20810[Abstract/Free Full Text]
27. Erickson, M. G., Alseikhan, B. A., Peterson, B. Z., and Yue, D. T. (2001) Neuron 31, 973-985[CrossRef][Medline] [Order article via Infotrieve]
28. Schonherr, R., Lober, K., and Heinemann, S. H. (2000) EMBO J. 19, 3263-3271[CrossRef][Medline] [Order article via Infotrieve]
29. Lee, A., Wong, S. T., Gallagher, D., Li, B., Storm, D. R., Scheuer, T., and Catterall, W. A. (1999) Nature 399, 155-159[CrossRef][Medline] [Order article via Infotrieve]
30. Marrion, N. V. (1997) Annu. Rev. Physiol. 59, 483-504[CrossRef][Medline] [Order article via Infotrieve]
31. Bahler, M., and Rhoads, A. (2002) FEBS Lett. 513, 107-113[CrossRef][Medline] [Order article via Infotrieve]
32. Houdusse, A., Silver, M., and Cohen, C. (1996) Structure 4, 1475-1490[Medline] [Order article via Infotrieve]
33. Atkinson, R. A., Joseph, C., Kelly, G., Muskett, F. W., Frenkiel, T. A., Nietlispach, D., and Pastore, A. (2001) Nat. Struct. Biol. 8, 853-857[CrossRef][Medline] [Order article via Infotrieve]
34. Niethammer, M., and Sheng, M. (1998) Methods Enzymol. 293, 104-122[Medline] [Order article via Infotrieve]
35. Levitan, I. B. (1999) Neuron 22, 645-648[CrossRef][Medline] [Order article via Infotrieve]
36. Johnson, J. P. J., and Zagotta, W. N. (2001) Nature 412, 917-921[CrossRef][Medline] [Order article via Infotrieve]
37. Gao, T., Bunemann, M., Gerhardstein, B. L., Ma, H., and Hosey, M. M. (2000) J. Biol. Chem. 275, 25436-25444[Abstract/Free Full Text]
38. Joiner, W. J., Khanna, R., Schlichter, L. C., and Kaczmarek, L. K. (2001) J. Biol. Chem. 31, 699-711
39. Doyle, D. A., Morais, C. J., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., and MacKinnon, R. (1998) Science 280, 69-77[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.